Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 91,575 shares at $62.81 ($5.7M) on 2023-09-15, disclosed to the SEC on 2023-09-19.
Scheduled sale ($5.7M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.81 | 16,242 | $1.0M | 18.0% |
| 2 | $62.81 | 16,242 | $1.0M | 18.0% |
| 3 | $61.64 | 8,425 | $519K | 9.2% |
| 4 | $61.23 | 25,333 | $1.6M | 27.4% |
| 5 | $61.23 | 25,333 | $1.6M | 27.4% |
| Total | $61.83 avg | 91,575 |
| $5.7M |
| 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |